Arkolith/Insider Trading/IOVA/Form 4

Vogt Frederick G

Interim CEO & General Counsel, DirectorIOVANCE BIOTHERAPEUTICS, INC. (IOVA) · full profile →Form 4 · filed Dec 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 2, 2025Option exercise(M)10K—$0469K
Dec 2, 2025Tax withholding(F)4K$2.14$9K465K
Dec 1, 2025Option exercise(M)42K—$0476K
Dec 1, 2025Tax withholding(F)18K$2.23$39K459K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 2, 2025Option exercise(M)10K—$010K
Dec 1, 2025Option exercise(M)42K—$0208K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-118168) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML